Investor Relations

Investor Relations

Latest News View All News

Dec 5, 2019 • 8:45 AM EST

Cerecor to Acquire Aevi Genomic Medicine

Nov 14, 2019 • 6:30 AM EST

Cerecor Reports Third Quarter 2019 Results

Nov 11, 2019 • 6:30 AM EST

Cerecor Announces Clinical Updates on CERC-301 and CERC-802

Stock Information View Detailed Stock Information

Nasdaq: CERC Cerecor, Inc.
Day Range
52 Week Range

Company Overview

Cerecor is an integrated biopharmaceutical company developing innovative therapies at the cutting edge of science. Our pipeline, filled with forward-thinking ideas, propels us forward. We are driven to change the lives of patients with rare orphan diseases in Pediatrics and Neurology.